GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
+17.45%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.17B
AUM Growth
+$356M
(+20%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
32.24%
Holding
194
New
14
Increased
88
Reduced
77
Closed
13
Top Buys
| 1 |
Chegg
CHGG
|
$53.2M |
| 2 |
eHealth
EHTH
|
$27.7M |
| 3 |
Enphase Energy
ENPH
|
$22M |
| 4 |
Sprout Social
SPT
|
$21.7M |
| 5 |
Zscaler
ZS
|
$12.8M |
Top Sells
| 1 |
CARB
Carbonite Inc
CARB
|
$18.1M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
$17M |
| 3 |
MDCO
Medicines Co
MDCO
|
$14.1M |
| 4 |
Etsy
ETSY
|
$14M |
| 5 |
Teladoc Health
TDOC
|
$12.4M |
Sector Composition
| 1 | Technology | 34.59% |
| 2 | Healthcare | 20.01% |
| 3 | Industrials | 12.27% |
| 4 | Consumer Discretionary | 8.61% |
| 5 | Consumer Staples | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ciena
CIEN
$16.5B
| $1.39M | 0.06% |
+32,475
| New | +$1.39M |
|
152
CytomX Therapeutics
CTMX
$346M
| $1.28M | 0.06% |
153,818
+421
| +0.3% | +$3.5K |
|
|
SHSP
153
DELISTED
SharpSpring, Inc.
SHSP
| $1.26M | 0.06% |
109,876
+50,538
| +85% | +$580K |
|
154
Ligand Pharmaceuticals
LGND
$3.27B
| $1.24M | 0.06% |
19,109
-13,842
| -42% | -$900K |
|
155
Organogenesis Holdings
ORGO
$638M
| $1.2M | 0.06% |
+250,000
| New | +$1.2M |
|
156
Iterum Therapeutics
ITRM
$28.2M
| $1.1M | 0.05% |
16,298
+150
| +0.9% | +$10.1K |
|
|
JNCE
157
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.07M | 0.05% |
122,282
-630
| -0.5% | -$5.5K |
|
158
Match Group
MTCH
$9B
| $958K | 0.04% |
11,671
-1,179
| -9% | -$96.8K |
|
|
AAN.A
159
DELISTED
AARON'S INC CL-A
AAN.A
| $898K | 0.04% |
+15,717
| New | +$898K |
|
160
Intellia Therapeutics
NTLA
$1.25B
| $882K | 0.04% |
60,107
+416
| +0.7% | +$6.1K |
|
161
Varonis Systems
VRNS
$6.24B
| $877K | 0.04% |
+33,846
| New | +$877K |
|
162
Sangamo Therapeutics
SGMO
$160M
| $859K | 0.04% |
102,635
+1,016
| +1% | +$8.5K |
|
|
ETTX
163
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $780K | 0.04% |
156,944
+15,932
| +11% | +$79.2K |
|
|
AKTS
164
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $768K | 0.04% |
96,038
-2,849
| -3% | -$22.8K |
|
165
Datadog
DDOG
$46B
| $735K | 0.03% |
+19,464
| New | +$735K |
|
166
Insulet
PODD
$24.4B
| $599K | 0.03% |
3,499
-28,686
| -89% | -$4.91M |
|
167
Merit Medical Systems
MMSI
$5.46B
| $557K | 0.03% |
17,850
-31,225
| -64% | -$974K |
|
168
Transact Technologies
TACT
$45M
| $454K | 0.02% |
41,399
+5,435
| +15% | +$59.6K |
|
|
RP
169
DELISTED
RealPage, Inc.
RP
| $386K | 0.02% |
7,185
+2,271
| +46% | +$122K |
|
|
TTOO
170
DELISTED
T2 Biosystems, Inc
TTOO
| $374K | 0.02% |
64
+20
| +45% | +$117K |
|
|
NBRV
171
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $352K | 0.02% |
1,066
+122
| +13% | +$40.3K |
|
|
TRTN
172
DELISTED
Triton International Limited
TRTN
| $344K | 0.02% |
8,559
-14,121
| -62% | -$568K |
|
|
ZAGG
173
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $340K | 0.02% |
+41,965
| New | +$340K |
|
174
Collegium Pharmaceutical
COLL
$1.24B
| $333K | 0.02% |
16,187
-24,519
| -60% | -$504K |
|
175
Live Nation Entertainment
LYV
$37.8B
| $320K | 0.01% |
4,475
-2,273
| -34% | -$163K |
|